Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MICALCL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CDKAL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NDST1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PRDM13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ELL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ARPP21 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C21orf59 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF225 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SAP30L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |